Fleury

Fleury S.A., established in 1926, is a prominent Brazilian healthcare provider specializing in diagnostic, treatment, and health management services. Operating within the Medical Testing & Clinical Laboratories and Healthcare industries, the company offers a comprehensive suite of medical solutions across Brazil. Its core business encompasses laboratory and imaging tests, advanced genomics, and integrated health management platforms designed to enhance patient care and outcomes. Fleury's commitment to innovation is evident in its diverse service portfolio, which includes diagnostic information, specialized check-up programs, reference laboratory services, and day clinic operations.

The company is structured into three key segments: Diagnostic Medicine, Integrated Medicine, and Dental. Through these divisions, Fleury delivers specialized services such as infusion centers, orthopedics, ophthalmology, and dental imaging tests. With an employee base exceeding 10,000 individuals and operating across 4 locations, Fleury maintains a significant operational footprint. To understand the expertise driving these operations, consider exploring Meet Fleury's team for insights into their leadership and professional staff.

Fleury generates substantial revenue, reported at $1.4B, underscoring its market leadership and scale within the Brazilian healthcare sector. The company's ticker symbol is BVMF: FLRY3. Its extensive service offerings, from routine diagnostics to complex medical treatments, position it as a critical player in the nation's health ecosystem, continually adapting to technological advancements and patient needs.